170 related articles for article (PubMed ID: 30666602)
1. Establishment of Two Dimensional (2D) and Three-Dimensional (3D) Melanoma Primary Cultures as a Tool for In Vitro Drug Resistance Studies.
Cruz Rodríguez N; Lineros J; Rodríguez CS; Martínez LM; Rodríguez JA
Methods Mol Biol; 2019; 1913():119-131. PubMed ID: 30666602
[TBL] [Abstract][Full Text] [Related]
2. Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing.
Vörsmann H; Groeber F; Walles H; Busch S; Beissert S; Walczak H; Kulms D
Cell Death Dis; 2013 Jul; 4(7):e719. PubMed ID: 23846221
[TBL] [Abstract][Full Text] [Related]
3. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.
Mulholland T; McAllister M; Patek S; Flint D; Underwood M; Sim A; Edwards J; Zagnoni M
Sci Rep; 2018 Oct; 8(1):14672. PubMed ID: 30279484
[TBL] [Abstract][Full Text] [Related]
4. Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.
Grissenberger S; Riedl S; Rinner B; Leber R; Zweytick D
Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183264. PubMed ID: 32151609
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
6. Tissue-engineered 3D melanoma model with blood and lymphatic capillaries for drug development.
Bourland J; Fradette J; Auger FA
Sci Rep; 2018 Sep; 8(1):13191. PubMed ID: 30181613
[TBL] [Abstract][Full Text] [Related]
7. PEG-peptide hydrogels reveal differential effects of matrix microenvironmental cues on melanoma drug sensitivity.
Tokuda EY; Jones CE; Anseth KS
Integr Biol (Camb); 2017 Jan; 9(1):76-87. PubMed ID: 28001152
[TBL] [Abstract][Full Text] [Related]
8. Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery.
Fontana F; Raimondi M; Marzagalli M; Sommariva M; Gagliano N; Limonta P
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948069
[TBL] [Abstract][Full Text] [Related]
9. Fibroblasts protect melanoma cells from the cytotoxic effects of doxorubicin.
Tiago M; de Oliveira EM; Brohem CA; Pennacchi PC; Paes RD; Haga RB; Campa A; de Moraes Barros SB; Smalley KS; Maria-Engler SS
Tissue Eng Part A; 2014 Sep; 20(17-18):2412-21. PubMed ID: 24548268
[TBL] [Abstract][Full Text] [Related]
10. 3D-3 Tumor Models in Drug Discovery for Analysis of Immune Cell Infiltration.
Osswald A; Hedrich V; Sommergruber W
Methods Mol Biol; 2019; 1953():151-162. PubMed ID: 30912021
[TBL] [Abstract][Full Text] [Related]
11. 3D modeling in cancer studies.
Atat OE; Farzaneh Z; Pourhamzeh M; Taki F; Abi-Habib R; Vosough M; El-Sibai M
Hum Cell; 2022 Jan; 35(1):23-36. PubMed ID: 34761350
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional culture models to study drug resistance in breast cancer.
Fisher MF; Rao SS
Biotechnol Bioeng; 2020 Jul; 117(7):2262-2278. PubMed ID: 32297971
[TBL] [Abstract][Full Text] [Related]
13. Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide.
Uematsu N; Zhao Y; Kiyomi A; Yuan BO; Onda K; Tanaka S; Sugiyama K; Sugiura M; Takagi N; Hayakawa A; Hirano T
Anticancer Res; 2018 Apr; 38(4):2101-2108. PubMed ID: 29599328
[TBL] [Abstract][Full Text] [Related]
14. Preparation, Drug Treatment, and Immunohistological Analysis of Tri-Culture Spheroid 3D Melanoma-Like Models.
Schäfer MEA; Klicks J; Hafner M; Rudolf R
Methods Mol Biol; 2021; 2265():173-183. PubMed ID: 33704714
[TBL] [Abstract][Full Text] [Related]
15. Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery.
Agarwal P; Wang H; Sun M; Xu J; Zhao S; Liu Z; Gooch KJ; Zhao Y; Lu X; He X
ACS Nano; 2017 Jul; 11(7):6691-6702. PubMed ID: 28614653
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiologically relevant in vitro tumor models for drug screening.
Das V; Bruzzese F; Konečný P; Iannelli F; Budillon A; Hajdúch M
Drug Discov Today; 2015 Jul; 20(7):848-55. PubMed ID: 25908576
[TBL] [Abstract][Full Text] [Related]
17. Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models.
Filipiak-Duliban A; Brodaczewska K; Kajdasz A; Kieda C
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163092
[TBL] [Abstract][Full Text] [Related]
18. Does the gastrointestinal microbiome contribute to the 'obesity paradox' in melanoma survival?
Langan EA; Grätz V; Billmann F; Zillikens D; Terheyden P
Br J Dermatol; 2018 Jul; 179(1):225-226. PubMed ID: 29663324
[No Abstract] [Full Text] [Related]
19. The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance.
Breslin S; O'Driscoll L
Oncotarget; 2016 Jul; 7(29):45745-45756. PubMed ID: 27304190
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.
Imamura Y; Mukohara T; Shimono Y; Funakoshi Y; Chayahara N; Toyoda M; Kiyota N; Takao S; Kono S; Nakatsura T; Minami H
Oncol Rep; 2015 Apr; 33(4):1837-43. PubMed ID: 25634491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
